Skip to main content
Glama

LiveDataLink

trials_search

Read-onlyIdempotent

Search ClinicalTrials.gov for clinical studies by condition, intervention/drug, sponsor, recruitment status, and/or location. Returns each trial's NCT id, title, status, conditions, lead sponsor, phase, and study type.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
termNoGeneral search term.
limitNoMax rows (default 10, max 50).
statusNoRecruitment status, e.g. 'RECRUITING', 'COMPLETED', 'TERMINATED'.
sponsorNoSponsor/organization, e.g. 'Pfizer'.
locationNoLocation, e.g. 'Houston' or 'Texas'.
conditionNoDisease/condition, e.g. 'breast cancer'.
interventionNoDrug/intervention, e.g. 'semaglutide'.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.2/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark the tool read-only, idempotent, and non-destructive. The description adds behavioral value by naming the external source and specifying the summary fields returned per trial, so the agent knows the shape of the result set without an output schema.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences: the first states what the tool searches and by which criteria, the second states what it returns. Every clause earns its place and the key info is front-loaded.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a 7-parameter read-only search tool with no required fields and no output schema, the description covers both query dimensions and return fields, which is sufficient to select and invoke it. It could add combination semantics (AND vs OR) or pagination details, but those are minor gaps given the schema annotations.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% and each parameter already has a useful description. The tool description largely restates those dimensions rather than adding new meaning, so it earns the baseline for schema-covered parameters.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses a specific verb ('Search') with a clear resource (ClinicalTrials.gov) and enumerates search dimensions as well as the exact returned fields (NCT id, title, status, etc.). This clearly distinguishes it from the sibling trials_details, which presumably fetches detailed protocol data for a specific trial.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description establishes a clear use case: querying clinical studies by condition, intervention, sponsor, status, and/or location. It does not explicitly name alternatives or state when not to use it, but the search-and-summary framing is enough to route an agent to this tool for filtering trials.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.3/5.0
Disambiguation2/5

Several tool clusters overlap heavily—company due-diligence and risk tools (counterparty_risk_score, company_trust_check, entity_dossier, issuer_diligence_dossier, resolve_entity, entity_resolve), carrier vetting tools, sanctions screening tools, and recall tools all have subtle boundary distinctions. While descriptions are detailed, an agent navigating 294 tools will frequently struggle to pick the right one.

Naming Consistency3/5

Most tools follow a readable snake_case domain-prefix pattern (fdic_, edgar_, sanctions_, congress_), which helps. However, verb placement is inconsistent—search_available_datasets vs cdc_dataset_query, resolve_entity vs entity_resolve—and synonyms like search, lookup, get, detail, fetch, and status are used interchangeably.

Tool Count1/5

294 tools is an extreme number for a single MCP server, far beyond what an agent can reliably hold in context or select from accurately. The presence of tool-group discovery helpers mitigates but does not solve the fundamental scale problem.

Completeness4/5

The data breadth is genuinely extensive, covering finance, health, legal, real estate, transportation, energy, cyber, education, and many other domains, often with generic query fallbacks. Still, some capabilities are shallow or incomplete—package tracking stops at a link, property tools are demo-only in places, and caselaw coverage is limited—so it is not a fully complete surface.